Ausgabe 2/2008
Inhalt (16 Artikel)
Symptoms after breast cancer treatment: are they influenced by patient characteristics?
Jean Yoon, Jennifer L. Malin, May Lin Tao, Diana M. Tisnado, John L. Adams, Martha J. Timmer, Patricia A. Ganz, Katherine L. Kahn
Breast cancer risk in women with radial scars in benign breast biopsies
Jena C. Berg, Daniel W. Visscher, Robert A. Vierkant, V. Shane Pankratz, Shaun D. Maloney, Jason T. Lewis, Marlene H. Frost, Karthik Ghosh, Amy C. Degnim, Kathleen R. Brandt, Celine M. Vachon, Carol A. Reynolds, Lynn C. Hartmann
Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion
M. Smollich, M. Götte, C. Kersting, J. Fischgräbe, L. Kiesel, P. Wülfing
HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer
Fabrice Andre, Chafika Mazouni, Cornelia Liedtke, Shu-Wan Kau, Debby Frye, Marjorie Green, Ana M. Gonzalez-Angulo, W. Fraser Symmans, Gabriel N. Hortobagyi, Lajos Pusztai
Predicting features of breast cancer with gene expression patterns
Xuesong Lu, Xin Lu, Zhigang C. Wang, J. Dirk Iglehart, Xuegong Zhang, Andrea L. Richardson
Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells
Zilal Kattan, Vanessa Minig, Pierre Leroy, Michel Dauça, Philippe Becuwe
Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women
Anne McTiernan, LieLing Wu, Vanessa M. Barnabei, Chu Chen, Susan Hendrix, Francesmary Modugno, Thomas Rohan, Frank Z. Stanczyk, C. Y. Wang
Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients
Jenny C. Chang, Andreas Makris, M. Carolina Gutierrez, Susan G. Hilsenbeck, James R. Hackett, Jennie Jeong, Mei-Lan Liu, Joffre Baker, Kim Clark-Langone, Frederick L. Baehner, Krsytal Sexton, Syed Mohsin, Tara Gray, Laura Alvarez, Gary C. Chamness, C. Kent Osborne, Steven Shak
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
Keun Seok Lee, Hyun Cheol Chung, Seock Ah Im, Yeon Hee Park, Chul Soo Kim, Sung-Bae Kim, Sun Young Rha, Min Young Lee, Jungsil Ro
Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients
Ragne K. Farmen, Oddmund Nordgård, Bjørnar Gilje, Fuad V. Shammas, Jan T. Kvaløy, Satu Oltedal, Reino Heikkilä
Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis
Dino Amadori, Oriana Nanni, Annalisa Volpi, Donata Casadei Giunchi, Maurizio Marangolo, Lorenzo Livi, Alberto Ravaioli, Andrea Paolo Rossi, Angelo Gambi, Stefano Luzi Fedeli, Davide Perroni, Emanuela Scarpi, Aldo Becciolini, Rosella Silvestrini
Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example
Joseph Pater, Dongsheng Tu, Lois Shepherd, James N. Ingle, Paul E. Goss
Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge
Guang-Yu Liu, Jing-Song Lu, Kun-Wei Shen, Jiong Wu, Can-Ming Chen, Zhen Hu, Zhen-Zhou Shen, Ting-Qiu Zhang, Zhi-Min Shao
Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial
Helen M. Milne, Karen E. Wallman, Sandy Gordon, Kerry S. Courneya
Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers
T. Byrski, J. Gronwald, T. Huzarski, E. Grzybowska, M. Budryk, M. Stawicka, T. Mierzwa, M. Szwiec, R. Wiśniowski, M. Siolek, S. A. Narod, J. Lubinski
Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis
Elise M. Pelletier, Boyung Shim, Seth Goodman, Mayur M. Amonkar